Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Druzhestven N IzsledovatelskifiledCriticalDruzhestven N Izsledovatelski
Priority to BG7950987ApriorityCriticalpatent/BG50303A1/en
Publication of BG50303A1publicationCriticalpatent/BG50303A1/en
The composition is used in human medicine. It has both a vessel-stabilizing and an anti-phlogistic effect with potencing influence of the vehiculum. The composition contains in percent weight: polymerisate ofacrylic acid 2.5-3.5; mono, di, tri, tetra β- hydroxyethyl rutozit 2-3; 1-r-chlorbenzoyl-2-methyl-5-methoxy-3-indolyl acetic acid from 1 to 5; polyethylene glycol 400 to 49.7 to 53.25; sodium benzoate 0.25-0.5; propylene glycol from 8 to 15; ethyl alcohol 96 degree from 25 to 35. The method consists of preparing a water-free gel base by using the alkalising effect of sodium benzoate included in the composition as a preservative. The solutions of the active substances are added to the gel base.
BG7950987A1987-04-241987-04-24Dermatological composition and a method for its preparation
BG50303A1
(en)
Preparations for topical use containing depolymerized deoxyribonucleic acids to reduce unsightly defects of the epidermis of the face and some skin areas of the body